JP2024515215A5 - - Google Patents

Info

Publication number
JP2024515215A5
JP2024515215A5 JP2023565466A JP2023565466A JP2024515215A5 JP 2024515215 A5 JP2024515215 A5 JP 2024515215A5 JP 2023565466 A JP2023565466 A JP 2023565466A JP 2023565466 A JP2023565466 A JP 2023565466A JP 2024515215 A5 JP2024515215 A5 JP 2024515215A5
Authority
JP
Japan
Application number
JP2023565466A
Other languages
Japanese (ja)
Other versions
JPWO2022229907A5 (https=
JP2024515215A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/053973 external-priority patent/WO2022229907A1/en
Publication of JP2024515215A publication Critical patent/JP2024515215A/ja
Publication of JPWO2022229907A5 publication Critical patent/JPWO2022229907A5/ja
Publication of JP2024515215A5 publication Critical patent/JP2024515215A5/ja
Pending legal-status Critical Current

Links

JP2023565466A 2021-04-29 2022-04-28 抗菌剤及び抗癌剤 Pending JP2024515215A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163181492P 2021-04-29 2021-04-29
US63/181,492 2021-04-29
PCT/IB2022/053973 WO2022229907A1 (en) 2021-04-29 2022-04-28 Antimicrobial and anticancer agents

Publications (3)

Publication Number Publication Date
JP2024515215A JP2024515215A (ja) 2024-04-05
JPWO2022229907A5 JPWO2022229907A5 (https=) 2025-04-30
JP2024515215A5 true JP2024515215A5 (https=) 2025-04-30

Family

ID=81598080

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023565466A Pending JP2024515215A (ja) 2021-04-29 2022-04-28 抗菌剤及び抗癌剤

Country Status (8)

Country Link
EP (1) EP4330238A1 (https=)
JP (1) JP2024515215A (https=)
KR (1) KR20240004303A (https=)
CN (1) CN117295720A (https=)
AU (1) AU2022267897A1 (https=)
CA (1) CA3216783A1 (https=)
IL (1) IL307990A (https=)
WO (1) WO2022229907A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202448502A (zh) * 2023-02-20 2024-12-16 日商大鵬藥品工業股份有限公司 Ftd・tpi調配劑、pd-1路徑拮抗劑、及vegf路徑拮抗劑之併用
WO2026074499A1 (en) * 2024-10-03 2026-04-09 Geistlich Pharma Ag Methods and compositions for inhibiting c-myc

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1160443B (de) * 1961-11-30 1964-01-02 Hoechst Ag Verfahren zur Herstellung von Tetrahydro-oxathiazin-dioxyden
GB8617482D0 (en) 1986-07-17 1986-08-28 Geistlich Soehne Ag Pharmaceutical composition
WO2013190355A1 (en) * 2012-06-18 2013-12-27 Geistlich Pharma Ag Oxathiazine derivatives as antibacterial and anticancer agents
MX392353B (es) * 2014-12-19 2025-03-24 Geistlich Pharma Ag Procedimientos para preparar compuestos de tipo oxatiazina
CA3140981A1 (en) * 2019-05-22 2020-11-26 Geistlich Pharma Ag Oxathiazin compounds for inhibiting gapdh

Similar Documents

Publication Publication Date Title
JP2024515215A5 (https=)
BR102022025291A2 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102022026909A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13174U (https=)
BY13167U (https=)
CN307045793S (https=)
CN307045621S (https=)
CN307045531S (https=)
CN307045207S (https=)
CN307045088S (https=)
CN307044914S (https=)
CN307044451S (https=)
CN307044388S (https=)
BY23963C1 (https=)
BY13176U (https=)
BY13175U (https=)
CN307047763S (https=)